Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
NCT00002524 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2012-07-30
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
Conditions
Interventions
- BIOLOGICAL
-
Bleomycin Sulfate
- BIOLOGICAL
- DRUG
- DRUG
- DRUG
- DRUG
-
Doxorubicin Hydrochloride (DOX)
- DRUG
-
Etoposide
- DRUG
- DRUG
-
Ifosfamide
- DRUG
-
Leucovorin calcium
- DRUG
-
Methotrexate
- DRUG
-
Methylprednisolone
- DRUG
-
Pentamidine
- DRUG
- DRUG
-
Vincristine Sulfate
- DRUG
-
Zidovudine (AZT)
- RADIATION
-
Radiation Therapy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Peter W. McLaughlin, MD · M.D. Anderson Cancer Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-06-30
- Primary Completion
- 2005-10-31
- Completion
- 2005-10-31
Countries
- United States
Study Locations
More Related Trials
-
Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
NCT00020943 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT00003541 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002552 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002510 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma
NCT00002982 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
NCT00032149 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002521 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT00742924 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
NCT00792948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
NCT00004231 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00003402 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00005613 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00002481 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002697 ·Status: COMPLETED ·Phase: PHASE2
-
Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
NCT02862275 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
NCT00040690 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002592 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma
NCT00005021 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00003957 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003815 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
NCT02112916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
NCT00003215 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma
NCT00003632 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma
NCT00669812 ·Status: UNKNOWN ·Phase: PHASE2
-
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
NCT00641381 ·Status: COMPLETED ·Phase: PHASE1